Subutex (Buprenorphine) 8mg

Buy Buprenorphine 8mg Tablets Research Chemical Online – USA, Europe & Worldwide

Welcome to RChems EU, a globally trusted supplier of high-purity research chemicals serving academic, pharmaceutical, and forensic laboratories across five continents. Our Buprenorphine 8mg Tablets (the active ingredient in Subutex) offer researchers a standardized, analytically verified reference material for forensic toxicology, opioid receptor pharmacology, and analytical method development.

Buprenorphine is a semi-synthetic opioid partial agonist derived from thebaine, belonging to the oripavine class of opioid analgesics. It exhibits high-affinity partial agonism at the μ-opioid receptor (MOR), antagonism at the κ-opioid receptor (KOR), and weak partial agonism at the δ-opioid receptor (DOR). As a research chemical, Buprenorphine serves as a critical reference standard for studying opioid receptor pharmacology, developing analytical methods for forensic toxicology, and understanding the structure-activity relationships of semi-synthetic opioid derivatives. Its unique partial agonist profile, characterized by a ceiling effect on respiratory depression, makes it a compound of significant pharmacological interest.

When you buy Buprenorphine 8mg tablets for research from RChems EU, you receive a rigorously synthesized, analytically verified reference material at ≥99% purity. Each tablet delivers a precise 8mg dose of Buprenorphine, eliminating weighing variability and providing a consistent matrix-matched calibration standard for laboratory analysis. Whether your laboratory is located in the USA, Germany, Japan, Australia, or Brazil, our worldwide logistics network ensures rapid, discreet delivery directly to your institutional address.

Key Features & Benefits

• ≥99% Verified Purity: Every batch undergoes independent orthogonal testing using HPLC-DAD, ¹H/¹³C NMR, and LC-MS/MS. Total impurities are maintained below 1%, ensuring reproducible results in receptor binding and analytical assays.
• Standardized 8mg Tablet Format: Pre-dosed, homogeneous tablets eliminate the need for analytical weighing of neat compound, reducing preparation time and potential gravimetric error. Ideal for dissolution testing, calibration curve generation, and matrix-matched reference standards.
• Discreet & Secure Packaging: Plain, unmarked outer boxes with zero chemical identifiers. Vacuum-sealed inner blister packs protect against moisture, oxidation, and tampering. No mention of “Buprenorphine,” “opioid,” or “research chemical” on any external shipping label or customs declaration.
• Fast Worldwide Delivery: Strategic dispatch hubs in the European Union and United States. Typical transit: 3–7 business days to USA, UK, and Canada; 5–12 days to Australia, New Zealand, and Japan; 7–14 days to South America and South Africa.
• Batch-Specific Certificate of Analysis (CoA): Every order includes a detailed CoA with chromatograms, retention times, purity percentage, residual solvent analysis, and heavy metals testing. Full analytical data available upon request prior to purchase.
• Flexible Quantity Options: Available in 60, 120, 180, 240, or 300 tablet quantities to suit studies of any scale.

Product Specifications

Applications & Usage

Buprenorphine 8mg Tablets are strictly intended for forensic, analytical, and in-vitro research applications only. Typical laboratory uses include:

• Forensic Toxicology Reference Standard: Employ as a certified comparison material for the identification and quantification of buprenorphine and its major metabolite (norbuprenorphine) in biological matrices (blood, urine, tissue) using LC-MS/MS, GC-MS, or HPLC-DAD in accredited forensic laboratories.
• Analytical Method Development & Validation: Utilize matrix-matched tablets to develop and validate extraction protocols, calibration curves, and quality control procedures for opioid screening in clinical and forensic settings.
• Opioid Receptor Binding Assays: Investigate Buprenorphine’s affinity (Ki) and functional activity at μ-opioid (MOR), κ-opioid (KOR), and δ-opioid (DOR) receptors using radioligand displacement (e.g., [³H]-DAMGO for MOR, [³H]-U69,593 for KOR) or functional GTPγS binding assays in transfected cell lines or native membrane preparations.
• Partial Agonist Pharmacology Studies: Characterize the ceiling effect, intrinsic efficacy, and receptor internalization kinetics of Buprenorphine compared to full opioid agonists (e.g., fentanyl, morphine, heroin) using in-vitro models.
• Pharmacokinetic Reference Material: Serve as a certified standard for in-vitro permeability studies (Caco-2, MDCK), plasma protein binding assays, and metabolic stability profiling using human liver microsomes (HLM) or recombinant CYP450 isoforms (primarily CYP3A4 and CYP2C8).
• Dissolution Testing & Quality Control: Use as a reference material for dissolution testing apparatus calibration and pharmaceutical quality control method development.
• Stability Indicating Studies: Employ in forced degradation studies (thermal, photolytic, hydrolytic, oxidative) to identify degradation products and validate stability-indicating HPLC methods.

Researchers are strongly encouraged to follow institutional chemical hygiene plans and consult peer-reviewed literature for comparative pharmacological data. This product is not for in-vivo administration in vertebrate animals without explicit IACUC approval specifically citing its use as a reference standard.

Purity & Testing

At RChems EU, we understand that research reproducibility begins with compound integrity. Every batch of 99% pure Buprenorphine 8mg tablets undergoes a comprehensive, multi-tiered analytical workflow before release:

1. High-Performance Liquid Chromatography (HPLC-DAD): Quantifies purity against a certified reference standard at dual wavelengths (210 nm and 280 nm). Acceptance criterion: ≥99.0% main peak area. All impurities ≥0.05% are reported with retention times.
2. Liquid Chromatography-Mass Spectrometry (LC-MS/MS): Confirms molecular ion [M+H]⁺ at m/z 468.3 and characteristic fragmentation pattern (loss of water, cleavage of the cyclopropylmethyl group). Rules out isobaric contaminants and synthetic byproducts.
3. Nuclear Magnetic Resonance (¹H and ¹³C NMR): Unambiguously confirms structural identity, including the oripavine skeleton and the 7α-(1-hydroxy-1,2,2-trimethylpropyl) side chain. Verifies absence of unexpected synthetic intermediates or stereoisomers.
4. High-Resolution Mass Spectrometry (HRMS-TOF): Provides exact mass measurement (calculated for C₂₉H₄₁NO₄: 467.3036; observed: 467.3034 ± 2 ppm) to rule out isobaric contaminants and confirm elemental composition.
5. Karl Fischer Coulometry: Ensures moisture content below 0.5%, critical for long-term stability of the tablet matrix.
6. Content Uniformity Testing (USP <905>): Random sampling of 10 tablets from each batch ensures each individual tablet contains 8mg ± 10% of active ingredient, with relative standard deviation (RSD) <6%.
7. Residual Solvent Analysis (GC-FID): Quantifies residual organic solvents from synthesis per ICH Q3C guidelines.
8. Dissolution Testing (USP <711>): Performed on representative samples to ensure consistent release characteristics for dissolution method development.

Only batches that pass all eight checkpoints are released for distribution. This rigorous approach means when you buy Buprenorphine for research from RChems EU, you eliminate batch-to-batch variability—a primary cause of non-reproducible results in opioid pharmacology and forensic toxicology.

Safety & Handling Guidelines

WARNING: For research use only. Not for human or animal consumption, therapeutic application, veterinary use, or any form of in-vivo administration outside approved controlled substance protocols.

• Personal Protective Equipment (PPE): Nitrile gloves (double-gloving recommended), laboratory coat, and chemical splash goggles mandatory when handling tablets or any dissolved solutions. Replace gloves immediately if contaminated.
• Ventilation: All manipulations must be performed inside a certified chemical fume hood or glove box. Avoid crushing tablets or generating airborne particulates. Use HEPA-filtered vacuum for spill cleanup.
• First Aid – Skin Contact: Wash immediately with copious soap and water for at least 15 minutes. Remove contaminated clothing. Seek medical evaluation if irritation develops.
• First Aid – Eye Contact: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing for at least 15 minutes. Seek immediate medical attention.
• First Aid – Inhalation: Move to fresh air immediately. Administer oxygen if breathing difficulty occurs. If breathing has stopped, perform artificial respiration. Seek immediate medical attention.
• First Aid – Accidental Ingestion: Do not induce vomiting. Rinse mouth with water. Seek immediate emergency medical care and provide this Safety Data Sheet (SDS) to treating physician.
• Spill Management: Isolate area, restrict access. Wearing full PPE, collect tablets mechanically using a dustpan and brush into a sealed hazardous waste container. Decontaminate surfaces with 70% ethanol followed by soap and water.
• Disposal: Comply with all local, state, and federal regulations for opioid derivatives and research chemicals. Incineration via a licensed hazardous waste vendor is strongly recommended.

Global Shipping & Discreet Delivery

RChems EU prioritizes your privacy, your research continuity, and the integrity of your supply chain. Our shipping protocols are engineered to attract zero unnecessary attention from customs, couriers, or third parties.

• Plain Outer Packaging: Standard corrugated cardboard boxes or Tyvek padded envelopes. No company logos, no chemical names, no hazard diamonds. Return address is a generic “Fulfillment Department” or “Logistics Center” with no mention of RChems EU.
• No Chemical Identifiers on Labels: Shipping labels and commercial invoices never list “Buprenorphine,” “opioid,” “Subutex,” or “research chemical.” Typical customs descriptions: “Laboratory consumables,” “Non-hazardous solid reference material,” “Inert polymer samples for analysis,” or “In vitro diagnostic reagents (non-human).”
• Vacuum-Sealed & Tamper-Evident: Each blister pack is heat-sealed in food-grade mylar, then vacuum-sealed a second time in an opaque outer pouch. Eliminates moisture ingress and evidence of tampering. Seals show visible evidence if opened during transit.
• Worldwide Coverage: We ship to all 50 US states (where local law permits research use), Canada, United Kingdom, EU Schengen zone, Switzerland, Norway, Australia, New Zealand, Japan, South Korea, and South Africa.
• Real-Time Tracking: DHL Express, FedEx Priority, or UPS Worldwide tracking number provided within 24 hours of dispatch. All shipments are insured for full commercial value against loss or damage.

Shipping Tiers:
| Service Level | Transit Time | Cost | Features |
| :— | :— | :— | :— |
| Standard International Airmail | 10–20 business days | Free on orders >$250 | Tracking available in select countries, no signature required |
| Express Courier (DHL/FedEx/UPS) | 3–7 business days | Calculated at checkout | Insured, signature required, real-time GPS tracking |

Why Choose RChems EU?

• Verified ≥99% Purity: Independent batch testing via HPLC, LC-MS, NMR, and HRMS. No vague claims. Every CoA includes raw chromatograms, spectra summaries, and quantitative impurity data.
• Stealth Packaging Industry Standard: Over 10,000 successful deliveries to research institutions worldwide. Zero customs seizures directly attributable to packaging or labeling failure in the past 36 months.
• Fast Fulfillment: Orders placed before 2 PM EST (Monday–Friday) ship same business day. Weekend orders ship Monday. Tracking provided within 24 hours.
• Scientific Support Team: Available 6 days/week (Monday–Saturday) to answer solubility questions (e.g., “Best solvent for Buprenorphine extraction?”), stability inquiries, analytical method troubleshooting, and CoA interpretation.
• Flexible Quantities: Choose from 60, 120, 180, 240, or 300 tablets to match your research scale.
• Ethical Compliance Program: We actively screen for residential addresses and require institutional affiliation verification (university, research institute, or corporate R&D email domain) for all restricted research products. We do not sell to individuals in prohibited jurisdictions.

Legal & Safety Disclaimer

IMPORTANT – READ CAREFULLY BEFORE ORDERING:

Buprenorphine is a semi-synthetic opioid partial agonist and a controlled substance in most jurisdictions. Depending on jurisdiction, this compound may be classified as a controlled substance (Schedule III in the USA), prescription-only medicine, or research chemical subject to strict import/export restrictions. Specific legal statuses include:

• United States: Buprenorphine is a Schedule III controlled substance under the Controlled Substances Act (21 U.S.C. § 812). Legitimate in-vitro research use by licensed institutions with appropriate DEA registration and research exemptions may be permitted. Researchers must possess all required licenses and registrations.
• United Kingdom: Class C controlled substance under the Misuse of Drugs Act 1971.
• Germany: Prescription-only and controlled under the Betäubungsmittelgesetz (BtMG).
• Australia: Schedule 8 (Controlled Drug) under state and territory poisons standards.
• Canada: Schedule I controlled substance under the Controlled Drugs and Substances Act (CDSA).

RChems EU sells Buprenorphine 8mg Tablets strictly as a research chemical and analytical reference standard for in-vitro laboratory use only. This product is not for human or animal consumption, personal use, clinical application, self-medication, addiction treatment, or any form of in-vivo administration. No medical, therapeutic, or opioid-use-disorder treatment claims are made or implied.

By purchasing this product, you affirm, warrant, and legally bind yourself to the following:

• You are at least 18 years of age (21 years in certain jurisdictions including California and New York for research chemical purchases).
• You are a qualified researcher affiliated with a recognized academic institution, pharmaceutical company, forensic laboratory, contract research organization (CRO), or government agency.
• You possess any and all required licenses, permits, research exemptions, DEA registration (or equivalent national authority), and import authorizations necessary for the lawful acquisition, possession, storage, and handling of this controlled substance in your country, state, province, or territory.
• You will not transfer, resell, distribute, or otherwise provide this product to any third party without explicit written authorization from RChems EU.
• You will use this product exclusively as an analytical reference standard for legitimate scientific research purposes and in compliance with all applicable institutional, local, state, and federal laws, regulations, and guidelines.
• You will not attempt to consume, ingest, inhale, inject, or otherwise introduce this product into a living organism.

RChems EU reserves the right to refuse, cancel, or refund any order at its sole discretion, including but not limited to orders from residential addresses, P.O. boxes, freight forwarders, proxy services, or jurisdictions where Buprenorphine is explicitly prohibited without a license. No refunds will be issued for shipments seized by customs where the buyer failed to verify import legality and obtain required licenses prior to ordering. International buyers assume all risks associated with cross-border shipping, including seizure, delay, or destruction by customs authorities.

FAQ Section

Q1: What is Buprenorphine 8mg used for in research?
A: Buprenorphine is a semi-synthetic opioid partial agonist derived from thebaine. In research settings, it is used as an analytical reference standard for forensic toxicology (LC-MS/MS, GC-MS method development and calibration for buprenorphine and its metabolite norbuprenorphine), opioid receptor binding assays (μ, κ, δ receptor affinity and functional activity studies), partial agonist pharmacology research, in-vitro permeability and metabolic stability studies (Caco-2, human liver microsomes), dissolution testing method development, and stability-indicating assays. It is not for human or animal consumption.

Q2: Is Buprenorphine legal to buy for research?
A: Buprenorphine is a Schedule III controlled substance in the USA and is similarly controlled in most other countries. Legitimate in-vitro research use by licensed institutions with appropriate DEA registration (or equivalent national authority) and research exemptions may be permitted. You are solely responsible for verifying your local laws and obtaining any required licenses, permits, or registrations before ordering. RChems EU will not ship to jurisdictions without proper authorization. Contact our compliance team with your institutional affiliation and license documentation for a jurisdiction-specific assessment.

Q3: How discreet is your shipping packaging?
A: Extremely discreet. The outer package is a plain, unmarked box or padded envelope with no branding, no chemical names, no hazard warnings, and no logos. The return address is a generic “Fulfillment Department” or “Logistics Center” with no mention of RChems EU or “research chemicals.” The customs declaration lists only generic, non-suspicious terms such as “laboratory consumables,” “non-hazardous solid reference material,” or “in vitro diagnostic reagents (non-human).” Inside, the tablets are sealed in an opaque, vacuum-sealed blister pack with no external labeling. Even the courier tracking page shows only a nondescript sender name. We maintain strict compliance with all applicable shipping regulations for controlled substances to licensed researchers.

Q4: What is the exact purity level, and how is it tested?
A: Minimum 99% pure Buprenorphine as determined by HPLC-DAD at dual wavelengths (210 nm and 280 nm). Each batch’s Certificate of Analysis includes the exact purity percentage (typically 99.2–99.6%), representative chromatograms, LC-MS/MS total ion chromatogram, ¹H and ¹³C NMR spectrum summaries, residual solvent profile, heavy metals analysis, and moisture content. We use orthogonal analytical methods (HPLC + LC-MS + NMR + HRMS) to confirm both identity and purity. No batch with any single unspecified impurity exceeding 0.2% is ever released for sale.

Q5: How should I store Buprenorphine 8mg tablets after opening?
A: Store in the original sealed blister pack or transfer immediately to a tight, amber glass vial with a desiccant packet (silica gel, 3–5 grams). Keep at controlled room temperature (15–25°C / 59–77°F), away from direct sunlight, heat sources, open flames, oxidizing agents, and humidity exceeding 60%. Do not refrigerate or freeze, as condensation upon opening may degrade tablet integrity. Under proper storage conditions, chemical stability remains ≥98% for 36 months from the date of manufacture. Always allow the sealed container to reach room temperature before opening to minimize moisture uptake.

Q6: What quantity options are available?
A: Buprenorphine 8mg Tablets are available in five quantity options: 60 tablets, 120 tablets, 180 tablets, 240 tablets, or 300 tablets. This flexibility allows researchers to order appropriate amounts for pilot studies, full-scale experiments, or long-term reference standard storage. Volume discounts apply to larger quantities.

Q7: Can I receive a Certificate of Analysis before placing an order?
A: Absolutely. Contact our scientific support team with the product name (Buprenorphine 8mg Tablets), your institutional affiliation, DEA registration or equivalent license number (if applicable), and intended research application. We will provide a representative CoA from the current or most recent production batch, including HPLC purity percentage, impurity profile, chromatograms, and NMR summary. Full, lot-specific CoAs are included inside every shipment.

Q8: Are the tablets suitable for use as analytical standards?
A: Yes. These tablets are manufactured with pharmaceutical-grade excipients to provide a consistent matrix-matched reference material. For quantitative analysis, we recommend extracting the Buprenorphine from the tablet matrix using an appropriate solvent (e.g., methanol or acetonitrile) and comparing against a certified neat reference standard for absolute quantification. The tablet format is ideal for dissolution testing, calibration curve preparation, and method validation where a matrix-matched standard is preferred.

Q9: What is the major metabolite of Buprenorphine, and can it be studied with this standard?
A: The major metabolite of Buprenorphine is norbuprenorphine, formed by N-dealkylation primarily via CYP3A4. Researchers can use Buprenorphine reference standards to study metabolic pathways, quantify parent drug depletion, and identify norbuprenorphine formation in human liver microsome assays. For full metabolic profiling, we recommend pairing this standard with a certified norbuprenorphine reference material.

Q10: Can I request a different dosage or larger quantity?
A: For research institutions requiring alternative dosages (e.g., 2mg, 4mg, 12mg tablets) or larger quantities (500+ tablets), please contact our institutional sales team. We offer custom formulation and tableting services with the same ≥99% purity guarantee and full analytical testing (HPLC, LC-MS, NMR, HRMS). Minimum order quantities vary. Contact us for a quotation and to discuss your specific research requirements.

Q11: What solvents are recommended for extracting Buprenorphine from the tablet matrix?
A: For analytical extraction, methanol or acetonitrile are recommended. Typical procedure: Place one tablet in a volumetric flask, add 10 mL of methanol, sonicate for 15–20 minutes, then dilute to volume. Filter through a 0.45 µm PTFE filter before injection. For receptor binding assays, extract with DMSO to prepare a 10 mM stock solution, then dilute in assay buffer (final DMSO concentration <0.1%). Ensure complete extraction by verifying recovery against a certified neat reference standard.

Ready to advance your forensic toxicology and opioid receptor research? Order Buprenorphine 8mg Tablets today from RChems EU – where purity, precision, and discretion define every shipment.

For institutional inquiries, standing purchase orders, DEA-registered facilities, or custom dosing formats, please contact our scientific sales team. Valid research credentials and applicable licenses are required prior to shipment.